Get the Stockscreener App
238.56
0.09%
-0.21
After Hours:
238.58
0.02
+0.01%
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $238.56, with a volume of 652.04K.
It is down -0.09% in the last 24 hours and up +3.30% over the past month.
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$238.77
Open:
$239.33
24h Volume:
652.04K
Relative Volume:
1.14
Market Cap:
$19.95B
Revenue:
$12.71B
Net Income/Loss:
$435.50M
P/E Ratio:
46.32
EPS:
5.15
Net Cash Flow:
$843.20M
1W Performance:
+2.83%
1M Performance:
+3.30%
6M Performance:
+10.56%
1Y Performance:
+6.98%
1-Day Range:
$236.95
$242.74
1-Week Range:
$229.16
$242.74
52-Week Range:
$191.97
$247.99
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
238.56 | 19.95B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Why Labcorp (LH) is Poised to Beat Earnings Estimates Again - MSN
Labcorp Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
Labcorp to Provide Testing Device for Eli Lilly-Sponsored Lung Cancer Testing Program - Marketscreener.com
Is Labcorp Holdings Stock Underperforming the S&P 500? - MSN
Clinical Trials Support Services Market Poised for Notable Expansion by 2030, Driven by Substantial Investments in R&D from Pharmaceutical and Biopharmaceutical Companies - GlobeNewswire Inc.
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Holdings (NYSE:LH) Will Pay A Dividend Of $0.72 - Simply Wall St
Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 - Yahoo Finance
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Labcorp to Participate in J.P. Morgan Healthcare Conference - TipRanks
Labcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
Labcorp Declares Quarterly Cash Dividend for 2025 - TipRanks
Labcorp to Announce Fourth Quarter Financial Results on February 6, 2025 - The Malaysian Reserve
Labcorp Holdings Inc. (LH) Announces Upcoming Fourth Quarter 202 - GuruFocus.com
LABCORP DECLARES QUARTERLY DIVIDEND - GuruFocus.com
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp to Announce Q4 2024 Financial Results - TipRanks
Labcorp director Anderson sells $235,000 in stock - Investing.com India
Labcorp director Anderson sells $235,000 in stock By Investing.com - Investing.com South Africa
LabCorp stock upgraded to Outperform with positive outlook on cost synergies - Investing.com Canada
Labcorp Loses Appeal Of Gene-Testing Patent In $372M Case - Law360
Labcorp Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
Fed. Cir. Upholds Ravgen DNA Test Patent Challenged by Labcorp - Bloomberg Law
Should You Retain Labcorp Stock in Your Portfolio Right Now? - MSN
Labcorp Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
LABCORP AND U.H.S. TO PAY $388,667 TO RESOLVE FALSE CLAIMS ALLEGATIONS - 3B Media News
Is Labcorp (LH) Stock Undervalued Right Now? - Yahoo Finance
State says Labcorp, UT Medical Center operator violated False Claims Act - Lebanon Democrat
LabCorp, UHS Pay $388K to Settle Medicare Fraud Allegations - NewsBreak
LabCorp Headed Back to Court to Face Texas Medicaid Fraud Claims - Bloomberg Law
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Labcorp's New Alliance With Graves Gilbert Clinic Set to Boost Stock - MSN
What Does Labcorp Holdings Inc.'s (NYSE:LH) Share Price Indicate? - Simply Wall St
Labcorp Holdings Inc. (NYSE:LH) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed? - Yahoo Finance
Labcorp Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
Labcorp Settles Competition Suit Against Ex-Sales Exec - Law360
LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal - MSN
Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain? - Yahoo Finance
Labcorp Declares Quarterly Dividend - Kilgore News Herald
Labcorp bird flu test takes flight - BioWorld Online
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):